Pulmicort Respules is the first anti-inflammatorycorticosteroid formulated for inhalation using a nebulizer in this age group. Previously, no other inhaled corticosteroid has been approved for use in children younger than four years of age. This approval allows for treatment with an approved formulation in a significant, currently unserved pediatric asthma population, according to the agency.
